NCT01395329
Nebivolol and the Endothelin (ET)-1 System
See it on ClinicalTrials.gov ↗42 people
38.1%
61.9%
16 womenmiddle line = equal numbers26 men
- Phase
- PHASE4
- Paid for by
- University of Colorado, Boulder
- Finished
- 2016-12
- Health conditions
- Prehypertension, Hypertension
- Who could join
- Anyone
- Ages
- 45 Years – 65 Years
- Average age
- mean 56 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No hormone therapy
Women taking menopause hormones or gender-affirming hormones could not join.
“Use of hormone replacement therapy.”
- Only women past menopause
Women who could still get pregnant were turned away.
“All of the women in the study will be postmenopausal (at least 1 year from last menstrual cycle) and not receiving hormone replacement therapy (HRT) currently or in the preceding 3-year period.”
- No smokers
Women who smoke or use nicotine were turned away.
“Candidates who smoke (currently or in the past 7 years), report more than low-risk alcohol consumption as defined as no more than 14 standard drinks/wk and no more than 4 standard drinks/day for men and 7 standard drinks/wk and 3 standard d…”
Study titles and rules are shown in their original English.